» Articles » PMID: 24591768

HLA-G Polymorphism (rs16375) and Acute Rejection in Liver Transplant Recipients

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2014 Mar 5
PMID 24591768
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HLA-G molecules exhibit immunomodulatory properties that can delay graft rejection. The 14 bp insertion/deletion polymorphism (INDEL) (rs16375) influences the stability of final HLA-G mRNA and its soluble isoforms.

Objective: The present study aimed to investigate the possible association between this polymorphism and the incidence of acute rejection in Iranian liver transplant recipients.

Methods: Different genotypes were evaluated by PCR. The patients who had acute rejection within 6 months after transplantation were classified as acute rejection (AR) group, while others were considered as nonacute rejection (NAR) group.

Results: Among the recipients, 21 patients (21%) had at least one episode of AR, while the other 79 patients (79%) had normal liver function. No significant differences were found between the two groups regarding sex, MELD score, and primary liver disease. Also, no difference was observed concerning rs16375 genotype and allele frequency (P = 0.44, OR: 0.69; CI: 0.21-2.10).

Conclusion: The study results revealed no significant difference between the AR and the NAR groups regarding the 14 bp INDEL genotypes and alleles. Further studies are recommended to be conducted on other polymorphic sites as well as monitoring of serum HLA-G concentration in order to ascertain the potential implications of this marker in our population.

Citing Articles

Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation.

Liu S, Bos N, Verschuuren E, van Baarle D, Westra J Front Immunol. 2022; 13:902093.

PMID: 35769475 PMC: 9234285. DOI: 10.3389/fimmu.2022.902093.


Interleukin-28B rs12979860 C/T Polymorphism and Acute Cellular Rejection after Liver Transplantation.

Fereidooni H, Azarpira N, Yaghobi R, Vahdati A, Malek-Hoseini S Int J Organ Transplant Med. 2017; 8(1):28-33.

PMID: 28299025 PMC: 5347403.


Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage.

Silva P, Bier J, Paiatto L, Galdino Albuquerque C, Souza C, Fernandes L J Immunol Res. 2015; 2015:856707.

PMID: 26543876 PMC: 4620289. DOI: 10.1155/2015/856707.

References
1.
Rouas-Freiss N, LeMaoult J, Moreau P, Dausset J, Carosella E . HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?. Am J Transplant. 2002; 3(1):11-6. DOI: 10.1034/j.1600-6143.2003.30103.x. View

2.
Sheshgiri R, Rouas-Freiss N, Rao V, Butany J, Ramzy D, Krawice-Radanne I . Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant. 2008; 27(5):522-7. DOI: 10.1016/j.healun.2008.02.004. View

3.
Jin H, Li C, Xiao L, Shi B, Cai M, Li Z . Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation. Transplant Proc. 2012; 44(5):1259-61. DOI: 10.1016/j.transproceed.2012.01.141. View

4.
Tripathi P, Abbas A, Naik S, Agrawal S . Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens. 2004; 64(6):706-10. DOI: 10.1111/j.1399-0039.2004.00308.x. View

5.
Lila N, Carpentier A, Amrein C, Dausset J, Carosella E . Implication of HLA-G molecule in heart-graft acceptance. Lancet. 2000; 355(9221):2138. DOI: 10.1016/S0140-6736(00)02386-2. View